PEAK6
HELP

PEAK6’s Helus Pharma Inc. Common Stock HELP Stock Holding History

PEAK6’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Sell
43,417
-19,180
-31% -$95.9K ﹤0.01% 2164
2026
Q1 		$300K Sell
62,597
-220,910
-78% -$1.43M ﹤0.01% 2152
2025
Q4 		$2.78M Buy
283,507
+200,799
+243% +$1.29M 0.01% 1253
2025
Q3 		$487K Buy
82,708
+56,424
+215% +$400K ﹤0.01% 2152
2025
Q2 		$221K Hold
26,284
– – ﹤0.01% 2419
2025
Q1 		$167K Buy
+26,284
New +$228K ﹤0.01% 2484

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

PEAK6's HELP Position: Q2 2026 in Review

PEAK6 reduced its Helus Pharma Inc. Common Stock (HELP) stake by 31% in Q2 2026, selling an estimated $95.9K and leaving 43,417 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

PEAK6 first reported a position in HELP in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.78M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • PEAK6 held 43,417 shares of Helus Pharma Inc. Common Stock worth $287K as of Q2 2026.
  • PEAK6 sold 19,180 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $95.9K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2164 holding.
  • PEAK6 first reported a position in Helus Pharma Inc. Common Stock in Q1 2025 and has held it in 6 quarters since.
  • PEAK6's Helus Pharma Inc. Common Stock position peaked at $2.78M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.